Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan

Clinical trial NCT01004159 · TERMINATED

Trial details

NCT number: NCT01004159
Sponsor: Roswell Park Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2009-09-01
Primary completion: 2012-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.